Director/PDMR Shareholding

Centrica PLC
23 July 2024
 

Centrica plc (the 'Company')

23 July 2024

Notification of Transactions of Directors

The Company was notified by Computershare Limited that Centrica plc ordinary shares of 6 14/81 pence ('Shares') have been acquired through reinvestment of the Company's 2023 final dividend of 2.67 pence per share paid on 11 July 2024.

The following notification, made pursuant to Article 19 of the Market Abuse Regulation, provides further details.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Christopher O'Shea

2

Reason for the notification

a)

Position/status

Executive Director

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Centrica plc

b)

LEI

E26EDV109X6EEPBKVH76

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial

instrument, type of instrument

 

Identification code

Ordinary shares of 6 14/81 pence

 

 

GB00B033F229

b)

Nature of the transaction

Acquisition of Shares on behalf of a PDMR by Computershare Limited through reinvested dividends

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£1.3902

27,778.65687

d)

Aggregated information

 

Aggregated volume

 

-      Price

 

-      Total

 

 

27,778.65687 Shares

 

£1.39 per Share

 

£38,617.89

e)

Date of the transaction

23 July 2024

f)

Place of the transaction

London Stock Exchange (XLON)

 

Centrica plc is listed on the London Stock Exchange (CNA)
Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654
Legal Entity Identifier number: E26EDV109X6EEPBKVH76
ISIN number: GB00B033F229

 

 

                      

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Centrica (CNA)
UK 100

Latest directors dealings